Features of Immunocompetent Cells in the Patients With Chronic Lymphocytic Leukemia at Primary Diagnosis

Medical Immunology (Russia) - Russian Federation
doi 10.15789/1563-0625-2015-6-573-578
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SPb RAACI

Related search

The Impacts of Zanubrutinib on Immune Cells in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Regulatory T-Cells in Chronic Lymphocytic Leukemia

Mediterranean Journal of Hematology and Infectious Diseases
Infectious DiseasesHematology
2012English

Management of Patients With Chronic Lymphocytic Leukemia Treated With Lenalidomide

Clinical Journal of Oncology Nursing
Oncology
2010English

Circulating VE-cadherin in Patients With Controlled Chronic Lymphocytic Leukemia

Pathologia
2014English

Anticoagulant Therapy in Patients With Chronic Lymphocytic Leukemia Receiving Ibrutinib

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Coevolution of Leukemia and Host Immune Cells in Chronic Lymphocytic Leukemia

Cold Spring Harbor perspectives in medicine
BiochemistryMedicineGeneticsMolecular Biology
2017English

Chronic Lymphocytic Leukemia

Current Opinion in Hematology
Hematology
1998English

Chronic Lymphocytic Leukemia

Orvosi Hetilap
Medicine
2008English

DNA Methylation Profiles in Chronic Lymphocytic Leukemia Patients Treated With Chemoimmunotherapy

Clinical Epigenetics
GeneticsDevelopmental BiologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy